← All stories
● Covered by 1 source · 1 reportLow impact1 neutral

Gen Z VCs Host Event Advocating for US-Based Peptide Manufacturing Amid Regulatory Debate

🔄 Updated 9d ago
New to BrevFeed? We gather this story from every outlet covering it into one summary — ranked by real-world impact, not just the latest headline — so you never miss what matters. What is BrevFeed? →

Key points

  • Haus Fund VCs hosted a peptide advocacy event on a WWII Liberty ship.
  • The event promoted US-based pharmaceutical supply chains for peptides.
  • HHS recently allowed certain unapproved peptides for compounding.
  • FDA scientists have not endorsed the HHS policy due to lack of evidence.

Peptide Advocacy Event on Historic Ship

Roxana Grunenwald, Yuva Krishnapillai, and Elia Ahmadi, three Gen Z venture capitalists from Haus Fund, organized a black-tie event on the SS Jeremiah O’Brien, a World War II Liberty ship. Approximately 150 guests attended the event, where samples of peptides, including a GHK-Cu topical cream and dissolvable sublingual strips from Afterglow, were provided. The venue was chosen to symbolize American industrial strength and to advocate for reshoring the pharmaceutical supply chain to the United States.

Context of Regulatory Debate

The event took place during a period of debate regarding peptide regulation. The US Department of Health and Human Services (HHS) recently issued an interim policy decision permitting certain unapproved peptides for compounding. This decision is controversial, as FDA career scientists have not endorsed it, citing insufficient evidence for the safety or efficacy of the experimental peptides. Industry experts have expressed concerns that this policy could undermine the established clinical trial framework.

Implications for Peptide Market

The HHS decision potentially allows telehealth providers and compounding pharmacies to bypass traditional approval processes, creating a parallel market with less stringent regulation. The organizers of the event used this context to emphasize their call for American-made peptides, aiming to address sourcing concerns associated with the gray market.

✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →

The daily brief

One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.

One email a day. Unsubscribe in one click, any time.

Today's brief

Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.

~4 min · 3 stories · Nov 21

▶ Play today's brief Listen on Spotify

New every morning, and the back catalogue is archived by date.

Reporting from

Three Gen Z venture capitalists from Haus Fund hosted an event on a WWII ship to advocate for domestic peptide manufacturing. This event occurred amidst a controversial HHS policy decision allowing certain unapproved peptides for compounding, a move not endorsed by FDA scientists due to safety and efficacy concerns.